HIL Medical logo

A Consortium led by HIL wins major R&D grant by European Union

A Consortium led by HIL wins major R&D grant by European Union The European Commission managing Horizon 2020 – the EU Framework Program for Research and Innovation – today announced its decision to fully fund a proposal by HIL and its European partners THALES (France) and INFN (Italy). The project, with a total budget of €3.8M […]

Dr. Ehud (Udi) Netzer is named Chairman at HIL

Dr. Ehud (Udi) Netzer is named Chairman at HIL. Dr. Netzer joined HIL’s Board of Directors last year and was today appointed by HIL’s Board of Directors as Chairman. In recent months he was intimately involved with Israel’s response to the COVID-19 epidemic, as member of the National Security Caouncil’s COVID-19 Task Force.  Dr. Netzer is a seasoned technology leader […]

We’re on the Map! HIL featured in The Marker Magazine STARTUP NATION HIGH-TECH MAP:

We’re on the Map! HIL featured in The Marker Magazine STARTUP NATION HIGH-TECH MAP: The Marker magazine tells the story of HIL Medical and its unique Proton Therapy solution within the startup nation high-tech map project. HIL was featured as one of the Israeli startup which stand behind the trail of success in the thriving Israeli high-tech scene.  

HIL at JP Morgan Healthcare Conference – the CICC Israel Lounge

HIL at JP Morgan Healthcare Conference – the CICC Israel Lounge   HIL will partake in the CICC’s Israel Lounge, on January 13-14th, during the JP Morgan Healthcare conference. Come and meet 1×1 with our CEO Sagi Brink-Danan, to get the latest on our achievements to date, plans for the future, and financing activities. Email us to set […]

HIL awarded €2.5M in grant funding by the EU

HIL awarded €2.5M in grant funding by the EU The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation – today approved HIL’s Phase-II proposal, at a total budget of €3.3M. The positive funding decision, under Horizon 2020 SME instrument, followed an extensive review process, culminating in an in-person pitch […]

Dr. Ehud (Udi) Netzer joins HIL’s Board of Directors

Dr. Ehud (Udi) Netzer joins HIL’s Board of Directors Dr. Netzer is a seasoned technology leader with over 35 years of experience covering all phases of basic research, product development, engineering, commercialization and senior management. During the past 15 years Dr. Netzer served as CEO of Orbit Systems, Head of R&D of the Israel Atomic […]

HIL and CERN enter collaboration (and Globes coverage)

HIL and CERN announce collaboration (and Globes coverage) Novel technologies developed at CERN could be used in HIL’s system, helping to further reduce the size and cost of Proton Therapy systems and achieve HIL’s goal of making this important treatment modality accessible to every patient around the world. The new collaboration is supported by a […]

HIL and Hebrew University announce new R&D and manufacturing facility in Jerusalem

HIL and Hebrew University announce new R&D and manufacturing facility in Jerusalem Calcalist, one of Israel’s leading financial news outlets, published HIL’s plan to set up a new R&D and manufacturing center on a 700 square-meter space leased from the Hebrew University in Jerusalem.  HIL will use the new facility to complete the development of […]

HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report

HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report HIL is featured as one of 160 companies in the Aging Analytics Agency and Vetek association’s 2019 report on the Longevity Industry in Israel. The report is part of a collaborative project by the Global Longevity Consortium, consisting of the Biogerontology Research Foundation, Deep […]